Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,923
datasets available to search
ShareScore release 0.9.0
Dataset results
1,923 results for “compounds”
Fig. 2. 1H–1H COSY and key HMBC correlations for compounds 1 and 4–7 in Neritriterpenols A-G, euphane and tirucallane triterpenes from Euphorbia neriifolia L. and their bioactivity
Fig. 2. 1H–1H COSY and key HMBC correlations for compounds 1 and 4–7.
Fig. 5. Experimental and calculated ECD spectra for compounds 1–6 in MS/MS-based molecular networking accelerated discovery of germacrane-type sesquiterpene lactones from Elephantopus scaber L
Fig. 5. Experimental and calculated ECD spectra for compounds 1–6 in MeOH.
Fig. 5. Keys NOE correlations for compounds 3, 4, 5 in Prenylated cyclohexene-type meroterpenoids and sulfur-containing xanthones produced by Pseudopestalotiopsis theae
Fig. 5. Keys NOE correlations for compounds 3, 4, 5.
Fig. 14 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 14. The newly reported compounds of polymeric lignans.
Fig. 12 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 12. The newly reported compounds of seco-lignans.
Fig. 13 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 13. The newly reported compounds of norlignans.
Fig. 10 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 10. The newly reported compounds of benzofuran lignans.
Fig. 11 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 11. The newly reported compounds of oxyneolignans and non-oxyneolignans.
Fig. 5 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 5. The newly reported compounds of arylnaphthalenelactones lignans.
Fig. 6 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 6. The newly reported compounds of furofuran lignans.
Fig. 8 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 8. Basic skeletons of neolignans.
Fig. 3 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 3. The newly reported compounds of tetrahydrofuran lignans.
Fig. 1 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 1. Basic skeletons of lignans.
Fig. 9 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 9. The newly reported compounds of biphenyl lignans.
Fig. 7 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 7. The newly reported compounds of dibenzocyclooctene lignans.
Fig. 4 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 4. The newly reported compounds of arylnaphthalene lignans.
Fig. 2 in Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications
Fig. 2. The newly reported compounds of dibenzylbutane lignans.
Fig. 5. Experimental ECDs and calculated ECDs for compounds 4–7 in Undescribed specialised metabolites from the endophytic fungus Emericella sp. XL029 and their antimicrobial activities
Fig. 5. Experimental ECDs and calculated ECDs for compounds 4–7.
Fig. 8. Plausible biosynthesis pathway for compounds 1–11 in Humulane-type and germacrane-type sesquiterpenoids from the fruits of Xanthium spinosum Linn.
Fig. 8. Plausible biosynthesis pathway for compounds 1–11.
Fig. 4. Proposed fragmentation pathway for compound 3 in Cruciasides C-G, monoterpenoid glycosides from Cruciata articulata
Fig. 4. Proposed fragmentation pathway for compound 3; ESI negative mode.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.